Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.89%
SPX
+1.52%
IXIC
+1.88%
FTSE
+0.13%
N225
+0.05%
AXJO
-0.57%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
157.94B
Dividend Yield
0.00%
P/E Ratio
23.86
EPS
7.62
Revenue
33.42B
Avg. Volume
1.76M

About

What does AMGN do?
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
Sector
💻 Health Care
IPO
CEO
Employees
28,000
Headquarters
California, USA
Website
http://www.amgen.com

Recently from Cashu

publisher logo
Cashu

AMGEN's Biotech Innovations Transforming Autoimmune Disease Treatment and Patient Care

3 days ago
publisher logo
Cashu

AMGEN Leads Innovative Therapies for Autoimmune Disorders in Biotechnology's Transformative Era

5 days ago
publisher logo
Cashu

Amgen's Legal Battle Reflects Growing Tensions Over Drug Pricing and Government Regulations

15 days ago
Stocks
Health Care
amgn
AMGEN
NASDAQ: AMGN
-2.15 (-0.73%)
293.605
USD
At close at Aug 22, 20:34 UTC
Summary
News
Signals
Benchmarks
Financials